Vigil Neuroscience Revenue and Competitors
Estimated Revenue & Valuation
- Vigil Neuroscience's estimated annual revenue is currently $7.6M per year.
- Vigil Neuroscience's estimated revenue per employee is $95,475
- Vigil Neuroscience's total funding is $140M.
Employee Data
- Vigil Neuroscience has 80 Employees.
- Vigil Neuroscience grew their employee count by 25% last year.
Vigil Neuroscience's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | General Counsel | Reveal Email/Phone |
5 | SVP, Clinical and Medical Sciences | Reveal Email/Phone |
6 | Head Corporate Development | Reveal Email/Phone |
7 | VP, Head Neuroimmunology | Reveal Email/Phone |
8 | VP, Head Medical Sciences | Reveal Email/Phone |
9 | VP, Patient Advocacy | Reveal Email/Phone |
10 | SVP, Program Leadership and Portfolio Managemengt | Reveal Email/Phone |
Vigil Neuroscience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $413.3M | 324 | 0% | $634M | N/A |
#2 | $47.8M | 238 | 0% | N/A | N/A |
#3 | $2.4M | 12 | -52% | N/A | N/A |
#4 | $25.7M | 128 | 39% | N/A | N/A |
#5 | $12.9M | 64 | 129% | N/A | N/A |
#6 | $23.9M | 119 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.3M | 51 | -14% | N/A | N/A |
#9 | $1.8M | 367 | -4% | $538M | N/A |
#10 | $50M | 249 | 3% | N/A | N/A |
What Is Vigil Neuroscience?
Vigil Neuroscience is the world's first microglia-focused therapeutics company. Our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain's immune system. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.
keywords:N/A$140M
Total Funding
80
Number of Employees
$7.6M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vigil Neuroscience News
VIGIL NEUROSCIENCE, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K).
Vigil Neuroscience, Inc. - Christopher Verni appointed as General Counsel and Mary Thistle appointed to its Board of Directors -. CAMBRIDGE,...
Vigil Neuroscience is a microglia-focused therapeutics company focused on developing treatments for both rare and common neurodegenerative...
Eight years after Atlas Venture began probing a group of nervous system cells and their effects in Alzheimer’s and other neurological disorders, the venture creation firm launched a new startup in the field this week. Vigil Neuroscience launched Tuesday with $50 million in financing from Northp ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.6M | 80 | -14% | N/A |
#2 | $11.2M | 80 | -4% | N/A |
#3 | $21.6M | 80 | -4% | N/A |
#4 | $11.6M | 80 | 21% | N/A |
#5 | $21.6M | 80 | 135% | N/A |